Jyong Biotech Ltd (MENS)

Apr 04, 2026

MENS PE Ratio & Valuation, Is MENS Overvalued - Intellectia AI

Apr 04, 2026

Apr 01, 2026

Director of Jyong Biotech (MENS) files Form 3 showing 3,000 common shares - Stock Titan

Apr 01, 2026

Apr 01, 2026

Director Hsu Feng-Lin reports 3,000 Jyong Biotech (MENS) shares on Form 3 - Stock Titan

Apr 01, 2026

Apr 01, 2026

Director at Jyong Biotech (MENS) discloses holding 3,000 shares - Stock Titan

Apr 01, 2026

Apr 01, 2026

Jyong Biotech (MENS) director Fan Hung-Shu files initial Form 3 - Stock Titan

Apr 01, 2026

Apr 01, 2026

Jyong Biotech (MENS) director files Form 3 with no insider trades - Stock Titan

Apr 01, 2026

Mar 29, 2026

Jyong Biotech Ltd. (NASDAQ:MENS) Short Interest Down 22.7% in March - Defense World

Mar 29, 2026

Mar 27, 2026

Jyong Biotech Updates the Potential Clinical Benefits and Advantages of Its Plant-Derived Innovative Drug MCS-2 - Bitget

Mar 27, 2026

Mar 27, 2026

A plant-based prostate drug finished Phase III trials in the U.S. and Taiwan - Stock Titan

Mar 27, 2026

Mar 20, 2026

MENS Stock Price, Quote & Chart | JYONG BIOTECH LTD (NASDAQ:MENS) - ChartMill

Mar 20, 2026

Mar 16, 2026

Jyong Biotech Ltd PE Ratio (TTM) & PE Ratio (TTM) ChartsMENS - GuruFocus

Mar 16, 2026

Mar 15, 2026

Chinese firm sues Taiwan’s Jyong Biotech Ltd. in Cayman to enforce ¥152M China judgment - OffshoreAlert

Mar 15, 2026

Mar 15, 2026

Jyong Biotech Ltd. (NASDAQ:MENS) Sees Large Decrease in Short Interest - MarketBeat

Mar 15, 2026

Mar 12, 2026

Jyong Biotech 'not aware' of any material information amid share price movement - MSN

Mar 12, 2026

Mar 11, 2026

MENS Earnings History & Surprises | EPS & Revenue Results | JYONG BIOTECH LTD (NASDAQ:MENS) - ChartMill

Mar 11, 2026

Feb 28, 2026

MENS Should I Buy - Intellectia AI

Feb 28, 2026

Feb 26, 2026

Jyong Biotech (NASDAQ:MENS) Stock Price Down 12.3%Time to Sell? - MarketBeat

Feb 26, 2026

Feb 23, 2026

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Feb 23, 2026

Feb 13, 2026

Jyong Biotech Reports Transformative Period of Clinical Validation and Commercialization Attempt: Phase II Data Focuses on Dual Therapeutic Potential of MCS-8 in Oncology and Metabolic Health, Alongside Strategic Market Entry into Asia - The Manila Times

Feb 13, 2026

Feb 12, 2026

MENS Technical Analysis & Stock Price Forecast - Intellectia AI

Feb 12, 2026

Feb 12, 2026

Prostate cancer therapy also lowers cholesterol in 2-year trial - Stock Titan

Feb 12, 2026

Feb 10, 2026

CEO Fu-Feng Kuo, Jyong Biotech Ltd.'s (NASDAQ:MENS) largest shareholder sees value of holdings go down 23% after recent drop - Yahoo Finance

Feb 10, 2026

Feb 07, 2026

Jyong Biotech appoints Wei (Vivi) Zhang as chief financial officer By Investing.com - Investing.com India

Feb 07, 2026

Feb 06, 2026

Jyong Biotech appoints Wei (Vivi) Zhang as chief financial officer - Investing.com Nigeria

Feb 06, 2026

Feb 06, 2026

Jyong Biotech Appoints Veteran Capital Markets Executive Wei Zhang as Chief Financial Officer - TipRanks

Feb 06, 2026

Feb 02, 2026

Jyong Biotech Ltd. (NASDAQ:MENS) Short Interest Update - MarketBeat

Feb 02, 2026

Jan 30, 2026

Jyong Biotech subsidiary announces phase II data for MCS-8 - TipRanks

Jan 30, 2026

Jan 30, 2026

Jyong Biotech reports positive results from MCS-8 phase II trial - Investing.com

Jan 30, 2026

Jan 30, 2026

Prostate cancer trial drug also improves cholesterol in 2-year study - stocktitan.net

Jan 30, 2026

Jan 09, 2026

Jyong Biotech Reports Higher Assets but Deeper Shareholders’ Deficit in June 2025 Unaudited Results - TipRanks

Jan 09, 2026

Jan 09, 2026

Jyong Biotech Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 - MarketScreener

Jan 09, 2026

Jan 08, 2026

FLYEXCLUSIVE INC. (FLYX) Stock, Price, News, Quotes, Forecast and Insights - MSN

Jan 08, 2026

Dec 31, 2025

Axsome Therapeutics, Plug Power And Other Big Stocks Moving Higher On Wednesday - Benzinga

Dec 31, 2025

Dec 29, 2025

After the recent decline, Jyong Biotech Ltd. (NASDAQ:MENS) CEO Fu-Feng Kuo's holdings have lost 33% of their value - simplywall.st

Dec 29, 2025

Dec 23, 2025

Sidus Space, Starfighters Space And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga

Dec 23, 2025

Dec 22, 2025

Jyong Biotech (NASDAQ:MENS) Shares Gap UpStill a Buy? - MarketBeat

Dec 22, 2025

Dec 21, 2025

Jyong Biotech Ltd.(NasdaqGM: MENS) added to NASDAQ Biotechnology Index - marketscreener.com

Dec 21, 2025

Dec 19, 2025

Jyong Biotech addresses share price fluctuations amid lock-up expiry By Investing.com - Investing.com Nigeria

Dec 19, 2025

Dec 19, 2025

Jyong Biotech in Talks With Funds Interested in Buying Shares - marketscreener.com

Dec 19, 2025

Dec 19, 2025

Jyong Biotech addresses share price fluctuations amid lock-up expiry - Investing.com

Dec 19, 2025

Dec 19, 2025

Jyong Biotech in talks with investment funds for purchasing co's ordinary shares - marketscreener.com

Dec 19, 2025

Dec 19, 2025

Jyong Biotech ‘not aware’ of any material information amid share price movement - TipRanks

Dec 19, 2025

Dec 19, 2025

Jyong Biotech Responds to Share Price and Volume Movement - The Manila Times

Dec 19, 2025

Dec 18, 2025

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Dec 18, 2025